A Double-blinded, Parallel-group, Randomized, Active-controlled Phase 2 Clinical Trial to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of Intravenous HY-001 Versus Standard Colistin Methanesulfonate Sodium Monotherapy in Patients with Complicated Urinary Tract Infection (with or without pyelonephritis) or Acute Uncomplicated Pyelonephritis at Risk for Infection with Multidrug Resistant Gram-negative Pathogens.
Latest Information Update: 29 Sep 2020
At a glance
- Drugs Colistin/zidovudine (Primary) ; Colistimethate sodium
- Indications Gram-negative infections; Pyelonephritis; Urinary tract infections
- Focus Therapeutic Use
- Sponsors Helperby Therapeutics
- 29 Sep 2020 New trial record